Wave Life Sciences Ltd (WVE) — Cash Flow Quality Index
Latest as of December 2024:
-1.49x
Wave Life Sciences Ltd (WVE) has a Cash Flow Quality Index of -1.49x as of December 2024. Operating cash flow of $-43.65 Million is below net income of $29.25 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Wave Life Sciences Ltd (WVE) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-1.49x
Operating CF / Net Income
Operating Cash Flow
$-43.65 Million
USD
Net Income
$29.25 Million
USD
Data as of
Dec 2024
Most recent filing
Annual Cash Flow Quality Index for Wave Life Sciences Ltd (None–None)
Year-by-year earnings quality comparison for Wave Life Sciences Ltd. For live market cap and the full company financial profile, see WVE market cap overview.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.